Phase I study of KRP-AM1977X -Penetration of AM-1977 into otorhinolaryngological tissues

Kyorin Pharmaceutical Co.,LTD0 个研究点目标入组 15 人开始时间: 2015年2月9日最近更新: 2023年10月17日

试验速览

阶段: 1 期
状态: 已完成
发起方: Kyorin Pharmaceutical Co.,LTD
入组人数: 15

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

The concentration of AM-1977 in otorhinolaryngologic tissues was higher than that in plasma, indicating good transferability to these tissues. In the safety assessment, no major problem was observed in KRP-AM1977X.

研究设计

研究类型: Interventional

入排标准

年龄范围: >= 20age old 至 <= 80age old（—）
性别: All

入选标准

•Person with BMI that is more than 18.5 but less than 30.0, etc.

排除标准

•- Have a history of allergy or severe side effects to quinolone antibiotics.
•-Have a presence of severe renal dysfunction or significant hepatic disorder etc.

研究者

发起方

Kyorin Pharmaceutical Co.,LTD

相似试验

已完成

1 期

Phase I study of KRP-AM1977X (Clinical pharmacology study)

JPRN-jRCT2080222496Kyorin Pharmaceutical Co.,LTD31

已完成

3 期

Open-label study for the patients with otorhinolaryngological infection

JPRN-jRCT2080222863Kyorin Pharmaceutical Co.,LTD70

已完成

1 期

Phase I study of KRP-AM1977Y-

JPRN-jRCT2080225244Kyorin Pharmaceutical Co., Ltd.18

已完成

3 期

A Phase III , open-label study of KRP-AM1977Y in respiratory tract infectio

JPRN-jRCT2080223247Kyorin Pharmaceutical Co.,LTD78

已完成

1 期

Phase I study of KRP-AM1977X (Clinical pharmacological study)Japanese healthy adult male subjects

JPRN-jRCT2080225163Kyorin Pharmaceutical Co., Ltd.54